NasdaqGS - Delayed Quote • USD
10x Genomics, Inc. (TXG)
At close: 4:00 PM EDT
After hours: 6:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-15,197.00
-15,197.00
-33,606.00
-21,373.00
-217,898.00
Investing Cash Flow
133,492.00
133,492.00
-350,887.00
-106,729.00
-38,394.00
Financing Cash Flow
13,669.00
13,669.00
15,817.00
35,297.00
468,906.00
End Cash Position
359,284.00
359,284.00
227,353.00
596,073.00
688,644.00
Income Tax Paid Supplemental Data
4,927.00
4,927.00
3,925.00
8,660.00
280.00
Interest Paid Supplemental Data
436.00
436.00
841.00
1,222.00
1,670.00
Capital Expenditure
-49,524.00
-49,524.00
-131,661.00
-101,278.00
-38,394.00
Issuance of Capital Stock
--
--
--
--
482,267.00
Repayment of Debt
--
--
--
--
-31,256.00
Free Cash Flow
-64,721.00
-64,721.00
-165,267.00
-122,651.00
-256,292.00
12/31/2020 - 9/12/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TDOC Teladoc Health, Inc.
13.01
-2.40%
SDGR Schrödinger, Inc.
23.97
+2.70%
DOCS Doximity, Inc.
23.82
+0.97%
VEEV Veeva Systems Inc.
200.91
+0.91%
ACCD Accolade, Inc.
7.89
-14.15%
PGNY Progyny, Inc.
32.04
-1.42%
EVH Evolent Health, Inc.
27.65
-2.37%
WGS GeneDx Holdings Corp.
11.08
-0.81%
MNDR Mobile-health Network Solutions
23.99
+0.88%
GDRX GoodRx Holdings, Inc.
7.19
+1.55%